{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:11:19Z","timestamp":1790244679681,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T00:00:00Z","timestamp":1264032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes Chromosomes &amp; Cancer"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Deletion of the long arm of chromosome 20 is a common abnormality associated with myeloid malignancies. We characterized abnormalities of chromosome 20 as defined by metaphase cytogenetics (MC) in patients with myeloid neoplasms to define commonly deleted regions (CDR) and commonly retained regions (CRR) using genome\u2010wide, high resolution single nucleotide polymorphism array (SNP\u2010A) analysis. We reviewed the MC results of a cohort of 1,162 patients with myeloid malignancies, including myelodysplastic syndromes (MDS), MDS\/myeloproliferative neoplasia (MDS\/MPN), and acute myeloid leukemia (AML). We further analyzed a subcohort of 532 patients by SNP\u2010A using the Affymetrix Genome\u2010Wide Human SNP Array 6.0 and GeneChip Human Mapping 250K Nsp arrays. By MC, 5% (54\/1,162) harbored a deletion of 20q; in 30% (16\/54), del(20q) was the sole cytogenetic abnormality. By SNP\u2010A analysis, we identified del(20q) in 23 patients, 3 not detected by MC. In four cases, monosomy 20 with a marker chromosome by MC was proven to be an interstitial deletion of 20q by SNP\u2010A. We defined 2 CDR and 2 CRR on chromosome arm 20q: CDR1 spanned 2.5 Mb between bands 20q11.23 and 20q12, while CDR2 encompassed 1.8 Mb within 20q13.12. CRR1 spanned 1.9 Mb within 20q11.21 and CRR2 encompassed 2.5 Mb within 20q13.33. In contrast to other chromosomes frequently affected by deletions, no somatic copy neutral loss of heterozygosity (CN\u2010LOH) was detected. Our data suggest that SNP\u2010A is useful for the detection of cryptic aberrations of chromosome 20q and allows for a more precise characterization of complex karyotypes. Furthermore, SNP\u2010A allowed definition of a CDR on 20q. \u00a9 2010 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/gcc.20748","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T20:20:45Z","timestamp":1264105245000},"page":"390-399","source":"Crossref","is-referenced-by-count":54,"title":["Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome\u2010wide single nucleotide polymorphism array analysis"],"prefix":"10.1002","volume":"49","author":[{"given":"Jungwon","family":"Huh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon V.","family":"Tiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz P.","family":"Gondek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Jasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Makishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania M.","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl S.","family":"Theil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,21]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.744"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1182\/blood.V84.9.3086.3086","article-title":"Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes","volume":"84","author":"Asimakopoulos FA","year":"1994","journal-title":"Blood"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1998.5231"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203728"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2004.12.019"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203653"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0462-3"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2754"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2017"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001225"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-092304"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403988"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20573"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870110105"},{"key":"e_1_2_5_16_1","unstructured":"HuretJL.2009. Genetics DIM. Available at:http:\/\/atlasgeneticsoncology.org\/index.html"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205690"},{"key":"e_1_2_5_18_1","article-title":"SNP array\u2010based analysis of chromosome 17 reveals homozygous TP53 mutations due to copy number\u2010neutral loss of heterozygosity of 17p in advanced MDS and AML with cooperating deletions of chromosomes 5 and 7","author":"Jasek M","year":"2009","journal-title":"Leukemia"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06910.x"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2006.06.003"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204540"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-130435"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e328016847a"},{"key":"e_1_2_5_25_1","unstructured":"MitelmanF JohanssonB MertensF.2009. Mitelman database of chromosome aberrations in cancer. Available at:http:cgap.nci.nih.gov\/chromosomes\/mitelman"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-079673"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2008.04.007"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi223"},{"key":"e_1_2_5_29_1","first-page":"3424","article-title":"Molecular genetics of myeloid leukemia: Identification of the commonly deleted segment of chromosome 20","volume":"82","author":"Roulston D","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2004.01.001"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-167056"},{"key":"e_1_2_5_32_1","volume-title":"ISCN 2009. An International System for Human Cytogenetics Nomenclature","author":"Shaffer LG","year":"2009"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2006.11.003"},{"key":"e_1_2_5_34_1","first-page":"610","article-title":"UPD1p indicates the presence of MPL W515L mutation in RARS\u2010T, a mechanism analogous to UPD9p and JAK2 V617F mutation","volume":"3","author":"Szpurka H","year":"2008","journal-title":"Leukemia"},{"key":"e_1_2_5_35_1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2008"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.59"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1006\/geno.2000.6215"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/518809"}],"container-title":["Genes, Chromosomes and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fgcc.20748","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/gcc.20748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T21:00:34Z","timestamp":1697490034000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gcc.20748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,21]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1002\/gcc.20748"],"URL":"https:\/\/doi.org\/10.1002\/gcc.20748","archive":["Portico"],"relation":{},"ISSN":["1045-2257","1098-2264"],"issn-type":[{"value":"1045-2257","type":"print"},{"value":"1098-2264","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,21]]}}}